Exploring the anticancer potential of fluoro flavone analogues: insights from molecular docking and dynamics studies with Aurora Kinase B

Ahmad S, Raza K (2023) Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study. Mol Divers. https://doi.org/10.1007/s11030-023-10648-0

Ahmad S, Singh V, Gautam HK, Raza K (2023) Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2209673

Ahmed A, Shamsi A, Mohammad T, Hasan GM, Islam A, Hassan MI (2021) Aurora B kinase: a potential drug target for cancer therapy. J Cancer Res Clin Oncol 147(8):2187–2198. https://doi.org/10.1007/s00432-021-03669-5

Alturki NA, Mashraqi MM, Alzamami A, Alghamdi YS, Alharthi AA, Asiri SA, Ahmad S, Alshamrani S (2022) In-Silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2. Molecules (basel, Switzerland) 27(14):4391. https://doi.org/10.3390/molecules27144391

Chaput L, Martinez-Sanz J, Saettel N, Mouawad L (2016) Benchmark of four popular virtual screening programs: construction of the active/decoy dataset remains a major determinant of measured performance. J Cheminform 8(56):1V. https://doi.org/10.1186/s13321-016-0167-x

Chen YJ, Chen CM, Twu NF, Yen MS, Lai CR, Wu HH, Wang PH, Yuan CC (2009) Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients. Virchows Arch 455(5):431–440. https://doi.org/10.1007/s00428-009-0838-3

Elkins JM, Santaguida S, Musacchio A, Knapp S (2012) Crystal structure of human aurora B in complex with INCENP and VX-680. J Med Chem 55(17):7841–7848. https://doi.org/10.1021/jm3008954

Esposito F, Libertini S, Franco R, Abagnale A, Marra L, Portella G, Chieffi P (2009) Aurora B expression in post-puberal testicular germ cell tumours. J Cell Physiol 221(2):435–439. https://doi.org/10.1002/jcp.21875

Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DF, Honda R, Nigg EA, Gerloff DL, Earnshaw WC (2004) Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol 166(2):179–191. https://doi.org/10.1083/jcb.200404001

Goto H, Yasui Y, Nigg EA, Inagaki M (2002) Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells: Devot Mol Cell Mech 7(1):11–17. https://doi.org/10.1046/j.1356-9597.2001.00498.x

Hegyi K, Méhes G (2012) Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy. Pathol Oncol Res: POR 18(4):761–769. https://doi.org/10.1007/s12253-012-9534-8

Jung Y, Shin SY, Yong Y, Jung H, Ahn S, Lee YH, Lim Y (2015) Plantderived flavones as inhibitors of aurora B kinase and their quantitative structure-activityrelationships. Chem Biol Drug Des 85(5):574–585. https://doi.org/10.1111/cbdd.12445

Katayama H, Brinkley WR, Sen S (2003) The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22(4):451–464. https://doi.org/10.1023/a:1023789416385

Libertini S, Abagnale A, Passaro C, Botta G, Portella G (2010) Aurora A and Bkinases–targets of novel anticancer drugs. Recent Pat Anti-Cancer Drugdiscover 5(3):219–241. https://doi.org/10.2174/157489210791760517

Lokhande KB, Nagar S, Swamy KV (2019) Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: the computational approach. Sci Rep 9(1):1778. https://doi.org/10.1038/s41598-018-38332-6

Lokhande KB, Doiphode S, Vyas R, Swamy KV (2021) Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals mitoxantrone, leucovorin, birinapant, and dynasore as potent drugs against COVID-19. J Biomol Struct Dyn 39(18):7294–7305. https://doi.org/10.1080/07391102.2020.1805019

Lokhande K, Nawani N, Venkateswara SK, Pawar S (2022) Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach. J Biomol Struct Dyn 40(10):4376–4388. https://doi.org/10.1080/07391102.2020.1858165

Ma HT, Poon R (2020) Aurora kinases and DNA damage response. Mutat Res 821:111716. https://doi.org/10.1016/j.mrfmmm.2020.111716

Mansuri A, Lokhande K, Kore S, Gaikwad S, Nawani N, Swamy KV, Junnarkar M, Pawar S (2022) Antioxidant, anti-quorum sensing, biofilm inhibitory activities and chemical composition of Patchouli essential oil: in vitro and in silico approach. J Biomol Struct Dyn 40(1):154–165. https://doi.org/10.1080/07391102.2020.1810124

Matthews N, Visintin C, Hartzoulakis B, Jarvis A, Selwood DL (2006) Aurora A and B kinases as targets for cancer: will they be selective for tumors? Expert Rev Anticancer Ther 6(1):109–120. https://doi.org/10.1586/14737140.6.1.109

Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582–6594. https://doi.org/10.1021/jm300687e

Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2021) In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer. J Mol Model 28(1):17. https://doi.org/10.1007/s00894-021-05010-w

Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2023a) Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach. Mol Divers 27(3):1141–1162. https://doi.org/10.1007/s11030-022-10475-9

Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2023b) Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction. Mol Divers 27(5):2273–2296. https://doi.org/10.1007/s11030-022-10556-9

Ruchaud S, Carmena M, Earnshaw WC (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8(10):798–812. https://doi.org/10.1038/nrm2257

Shin SY, Lee Y, Kim BS, Lee J, Ahn S, Koh D, Lim Y, Lee YH (2018) Inhibitory effect of synthetic flavone derivatives on pan-aurora kinases: induction of G2/M Cell-cycle arrest and apoptosis in HCT116 human colon cancer cells. Int J Mol Sci 19(12):4086. https://doi.org/10.3390/ijms19124086

Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F, Terada Y (1998) Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Can Res 58(21):4811–4816

Vader G, Medema RH, Lens SM (2006) The chromosomal passenger complex: guiding Aurora-B through mitosis. J Cell Biol 173(6):833–837. https://doi.org/10.1083/jcb.200604032

van Gijn SE, Wierenga E, van den Tempel N, Kok YP, Heijink AM, Spierings D, Foijer F, van Vugt M, Fehrmann R (2019) TPX2/Aurora kinase A signaling asa potential therapeutic target in genomically unstable cancer cells. Oncogene 38(6):852–867. https://doi.org/10.1038/s41388-018-0470-2

Willems E, Dedobbeleer M, Digregorio M, Lombard A, Lumapat PN, Rogister B (2018) The functional diversity of Aurora kinases: a comprehensive review. Cell Div 13:7. https://doi.org/10.1186/s13008-018-0040-6

Yadav MK, Ahmad S, Raza K, Kumar S, Eswaran M, Pasha Km M (2023) Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. J Biomol Struct Dyn 41(5):1527–1539. https://doi.org/10.1080/07391102.2021.2021993

Zeng WF, Navaratne K, Prayson RA, Weil RJ (2007) Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme. J Clin Pathol 60(2):218–221. https://doi.org/10.1136/jcp.2006.036806